Table 2. Toxicities Reported with Treatment.

R-CHOP, Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

CTCAE, Common Terminology Criteria for Adverse Events.

DA-REPOCH, Dose-adjusted rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin.

All toxicities reported in our patient population are listed. Toxicities are graded according to CTCAE version 5.

R-CHOP	CTCAE v5 any grade	CTCAE v5 Grade 3 or higher
	No. (% of total population)
Any	10 (83%)	6 (50%)
Fatigue	6 (50%)	2 (17%)
Peripheral motor neuropathy	3 (25%)	0 (0%)
Heart failure	2 (17%)	2 (17%)
Febrile neutropenia	3 (25%)	3 (25%)
Lung infection	1 (8%)	1 (8%)
Rash	2 (17%)	0 (0%)
Thromboembolic event	1 (8%)	1 (8%)
Sepsis	1 (8%)	1 (8%)
Nausea and vomiting	1 (8%)	1 (8%)
Death	1 (8%)	1 (8%)
DA-REPOCH
Any	7 (78%)	3 (33%)
Fatigue	4 (44%)	0 (0%)
Peripheral motor neuropathy	1 (11%)	0 (0%)
Generalized muscle weakness	1 (11%)	1 (11%)
Mucositis	1 (11%)	1 (11%)
Nausea and vomiting	1 (11%)	1 (11%)
Death	0 (0%)	0 (0%)